How toxicity may relate to the safety in cancer treatment?
Best insight from top research papers
Toxicity in cancer treatment can significantly impact safety by causing adverse events that affect patient well-being and treatment outcomes. Skin toxicities, such as rashes and hair loss, can lead to physical discomfort and psychological distress, potentially resulting in treatment delays or discontinuation, affecting clinical outcomes . Adverse drug reactions and intravenous-related events are common safety risks faced by cancer patients, highlighting areas for improvement in patient care . Adoptive cell therapy (ACT) for cancer treatment, while beneficial, can also lead to toxicities like cytokine release syndrome and neurological toxicity, necessitating careful management to balance safety and efficacy . Additionally, cancer treatments can induce cardiovascular toxicity, potentially leading to long-term cardiovascular events even after therapy completion, emphasizing the importance of understanding and managing these risks for patient safety .
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
5 Citations | Toxic effects from cancer treatments, like chemotherapy and immunotherapy, can lead to cardiovascular issues, impacting the safety of cancer therapy and long-term well-being of survivors. |
3 Citations | Toxicity in cancer treatment impacts patient safety by affecting quality of life and treatment efficacy. Genomics plays a role in assessing patient risk of adverse events. |
7 Citations | Toxicities in adoptive cell therapy for cancer, like cytokine release syndrome and neurological toxicity, pose safety challenges. Understanding mechanisms and managing toxicities is crucial for treatment safety. |
5 Citations | Skin toxicity in cancer treatment can lead to physical discomfort, psychological distress, treatment delays, and discontinuation, impacting safety and clinical outcomes. Early prevention and management are crucial. |
| Toxicity in cancer treatment, such as adverse drug reactions from cytotoxic drugs, poses safety risks for patients, highlighting areas like care coordination and intravenous-related events that need improvement. |
Related Questions
What are the specific mechanisms of ocular toxicity of experimental and clinical oncology drugs/?4 answersOcular toxicity of experimental and clinical oncology drugs can occur due to various mechanisms. Retinopathy is the most frequent ocular toxicity observed, along with conjunctivitis, dry eye, keratitis, keratopathy, and uveitis. These toxicities can be caused by drugs such as HSP90 inhibitors and FGFR inhibitors, which have a high incidence of ocular toxicities. The onset of ocular toxicities can occur even at doses below the drug's maximum tolerated dose. Most ocular toxicities occur bilaterally, except for a few cases. About 60% of ocular toxicity cases require a temporary hold of the drug, but the majority of cases fully recover. The detailed progress and risks of ocular toxicities of anti-cancer drugs have been investigated, providing valuable information for their management and prevention.
Cancer response to internal toxicity5 answersCancer response to internal toxicity can vary depending on the type of treatment being used. Biological response modifiers, such as cytokines, can elicit toxicities characterized by fever, chills, malaise, and anorexia. The central nervous system (CNS) toxicity is also common in clinical trials evaluating biological response modifiers, although it can be difficult to determine the exact role of the modifier in producing CNS toxicity. Response Evaluation Criteria in Solid Tumors (RECIST) and the National Cancer Institute — Common Toxicity Criteria (NCI-CTC) Version 2.0 have been developed to standardize the evaluation of response and toxicity in cancer treatment. The gut microbiome has been shown to play a role in the response and toxicity to cancer treatment, including chemotherapy, immunotherapy, and radiation. High-dose ifosfamide+mesna (HD-IFO+M) has been found to have low toxicity in patients with advanced breast cancer, with continuous infusion over 24 hours being the best tolerated. Whole-body hyperthermia can lead to various toxic effects, including fatigue, edema, diarrhea, nausea, vomiting, and respiratory depression.
What are toxicological dose descriptors?5 answersToxicological dose descriptors are measurements used to describe the intensity of exposure to a chemical and its effects on biological organisms. These descriptors can include the computed tomography dosimetry index, which measures the spatial spread of dose in CT scans, and the equivalent rectangular width, which expresses the volume being imaged relative to the volume receiving the dose. Dose-response relationships are also important in toxicology, with curves typically showing a sigmoidal shape, progressing from no response at low concentrations to 100% response at high concentrations. The statistical risk of experiencing an effect from chemical exposure is influenced by factors such as dose, dose rate, and concentration. Machine learning algorithms can be used to predict toxicity using molecular descriptors, such as 1D and 2D descriptors, which improve the accuracy of models.
How does concentration affect cellular toxicity?2 answersConcentration plays a crucial role in cellular toxicity. High doses of toxicants can overcome cellular defense mechanisms and lead to cell damage. The molecular targets for cell toxicity are diverse and can involve depletion of cofactors, disruption of energy supplies, and altered ion homeostasis. The formation of reactive intermediates and their interaction with cellular macromolecules are often involved in the mechanism of cellular derangements. The cellular response to a toxic insult depends on the phenotypically determined repertoire of response open to the cell, as well as the quantitative and qualitative measures of the events induced by the toxicant. For example, low levels of toxins may induce terminal differentiation in cells, while higher concentrations may lead to apoptosis. Overall, concentration influences the severity and type of cellular response to toxicants, highlighting the importance of understanding the dose-response relationship in cellular toxicity.
Is immunotherapy as toxic as chemotherapy?3 answers
What kind of toxicity induced by ligand therapy?7 answers